Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2024-06-01
2025-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our aim in the study was to measure frailty in elderly individuals diagnosed with sarcopenia and to determine the level of frailty.
to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia and to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia according to the results of the evaluation and new rehabilitation programs on frailty, falls, kinesiophobia and balance resulting from sarcopenia and to be the basic data for the programs to be created.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Relationship Between Sarcopenia and Balance, Fear of Falling and Fall Risk in Older Female Patients
NCT06277193
Muscle Quality, Fall Concern and Lower Extremity Functionality in Older Women
NCT05758792
Comparison of Kinesiophobia, Balance, Falling and Walking Speeds of Elderly's With Physical Frailty With Alzheimer's
NCT05761665
The Impact of Frailty in Type 2 Diabetes
NCT05863611
Effects of Action Observation Training and Exercises Over 65 Years Old
NCT04759690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sarcopenia
According to EWGSOP2 criteria; individuals diagnosed with sarcopenia were included in the study by evaluating low muscle strength, low muscle quantity or quality, and low physical performance.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 65 years of age or older
3. Being diagnosed with primary sarcopenia by a specialist
4. To have the cooperation to perform the measurements
Exclusion Criteria
2. Not volunteering to participate in the study
3. History of trauma within the last six months (fracture, soft tissue injury, etc.)
4. Having undergone lower extremity surgery
65 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karabuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
METEHAN YANA
Supervisor, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Metehan Yana
Role: PRINCIPAL_INVESTIGATOR
Karabuk University
Ecem Çoroğlu, BD
Role: PRINCIPAL_INVESTIGATOR
Karabuk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karabük University
Karabük, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ye L, Liang R, Liu X, Li J, Yue J, Zhang X. Frailty and sarcopenia: A bibliometric analysis of their association and potential targets for intervention. Ageing Res Rev. 2023 Dec;92:102111. doi: 10.1016/j.arr.2023.102111. Epub 2023 Oct 29.
Alvarez-Bustos A, Carnicero-Carreno JA, Davies B, Garcia-Garcia FJ, Rodriguez-Artalejo F, Rodriguez-Manas L, Alonso-Bouzon C. Role of sarcopenia in the frailty transitions in older adults: a population-based cohort study. J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2352-2360. doi: 10.1002/jcsm.13055. Epub 2022 Jul 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Karabuk 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.